Loading...

NEXTGEN MPN PANEL

image not found

NABL Cap Accredited 
The NextGen MPN Panel at Metropolis Healthcare is a molecular diagnostic test designed to detect genetic mutations associated with Myeloproliferative Neoplasms (MPNs). This panel evaluates key driver mutations and additional clinically relevant variants to aid in diagnosis, prognosis, and therapy selection. Metropolis Healthcare uses high-depth Next-Generation Sequencing and validated bioinformatics pipelines to provide precise, actionable results. It is ideal for patients with suspected or confirmed MPNs requiring detailed molecular characterization for personalized treatment planning.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 35,000.00

Sample Type: Bone Marrow , EDTA Whole Blood

Fasting Not Required


Notes:N8300

Frequently Asked Questions (FAQ's):

What does the NextGen MPN Panel at Metropolis Healthcare include?
It analyzes driver and secondary mutations associated with Myeloproliferative Neoplasms to guide diagnosis and therapy decisions.

How does Metropolis Healthcare perform the MPN gene panel?
Metropolis Healthcare uses high-depth NGS and validated bioinformatics workflows to ensure accurate detection of clinically relevant mutations.

Who should consider taking this test at Metropolis Healthcare?
Patients with suspected or confirmed MPNs needing molecular profiling for diagnosis, prognosis, or therapy selection should consider this panel.

Is fasting required for the NextGen MPN Panel at Metropolis Healthcare?
No fasting is needed; the test is performed on blood samples (EDTA) as recommended by the clinician.

How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to sequencing and variant interpretation.

Can this test at Metropolis Healthcare help guide MPN treatment decisions?
Yes, identified mutations can inform therapy choice, risk stratification, and patient management strategies.

How accurate is the NGS analysis for the MPN panel at Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through deep sequencing coverage and strict quality control protocols.

Does this panel support long-term MPN management at Metropolis Healthcare?
Yes, molecular insights assist clinicians in monitoring disease progression and tailoring personalized treatment plans.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab